Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04238793 · ClinicalTrials.gov registry record · Phase 1
Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
A Phase 1 study, sponsored by Kolon Life Science.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT04238793: Completed Phase 1 study, sponsored by Kolon Life Science.
NCT04238793 is a Phase 1 study that has completed, run by Kolon Life Science. The registered enrollment target is 18 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04238793, a Phase 1 study, has completed, sponsored by Kolon Life Science.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
Escalating single-dose design study to determine the safety, tolerability, and analgesic activity of KLS-2031
Primary Outcome
Frequency and nature of AEs, laboratory test results, vital sign measurements, physical and complete neurological examinations, and 12-lead electrocardiograms (ECGs)
Interventions
- OTHER Placebo
- DRUG KLS-2031
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2020-04-16 |
| Est. Completion | 2023-10-18 |
| Phase | Phase 1 |
What the finished NCT04238793 record still lists
NCT04238793 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04238793 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04238793 about?
NCT04238793 is a clinical study titled "Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy". Escalating single-dose design study to determine the safety, tolerability, and analgesic activity of KLS-2031
What is the current status of trial NCT04238793?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2020-04-16. Estimated completion is 2023-10-18.
What interventions are being tested in trial NCT04238793?
The interventions under investigation include: Placebo (OTHER), KLS-2031 (DRUG).
Who is sponsoring clinical trial NCT04238793?
This trial is sponsored by Kolon Life Science, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04238793's enrollment target sits among peer trials
18 1720th of 2000 higher than 216 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI